The shingles vaccine protection lasts at least 7 years, but likely much longer

The shingles vaccine (Shingrix) protects against shingles for at least 7 years based on the longest studies completed so far. Researchers continue to follow vaccinated people to see how long immunity holds, but current evidence suggests protection remains strong well beyond that timeframe. Most people who receive the two-dose series will not need a booster.

Protection does not drop to zero after 7 years. Studies show that even if immunity weakens over time, vaccinated people who do get shingles experience milder cases with less pain and fewer complications than unvaccinated people. The vaccine remains more than 90% effective at preventing shingles in the first few years after vaccination.

Key Takeaways

  • Shingrix protection has been documented for at least 7 years, with ongoing studies tracking whether it lasts longer.
  • The vaccine is given as two doses, two to six months apart, and you need both doses for full protection.
  • Even if protection weakens over time, vaccinated people who develop shingles have less severe disease than unvaccinated people.
  • Booster doses are not currently recommended for most people, though the CDC may update guidance as more long-term data emerges.
  • Protection begins after the second dose, not after the first dose alone.

What the research shows about long-term protection

Shingrix was approved by the FDA in 2017, so researchers have now tracked vaccinated people for about 7 years. In those studies, protection against shingles remained above 90% through year 7. The vaccine was also 89% to 91% effective at preventing postherpetic neuralgia—the severe nerve pain that can follow shingles—in people who did develop the infection despite vaccination.

The CDC and vaccine manufacturers continue to monitor people who received Shingrix to understand how long protection lasts. Studies are ongoing, but there is no evidence yet that immunity drops sharply after 7 years. Some vaccines provide lifelong protection; others require boosters years later. For Shingrix, the answer is still being written as more time passes.

One reason researchers expect long-lasting protection is how Shingrix works. It is a recombinant vaccine, meaning it contains a piece of the varicella-zoster virus (the virus that causes shingles) made in a laboratory, not a weakened or inactivated whole virus. This type of vaccine tends to trigger a durable immune response.

Why you need two doses, not one

Shingrix requires two doses given two to six months apart. The first dose primes your immune system; the second dose strengthens and solidifies that response. Studies show that one dose alone provides only partial protection—around 50% to 60% in the first year. After the second dose, protection jumps to more than 90%.

If you received only the first dose, you should still get the second dose even if more than six months have passed. There is no maximum time between doses. The CDC recommends completing the series as soon as possible, but a delayed second dose still provides the benefit of full protection once you receive it.

How protection compares to the older shingles vaccine

Before Shingrix, the only shingles vaccine available was Zostavax, a live attenuated vaccine given as a single dose. Zostavax protection dropped significantly over time—effectiveness fell from about 50% in the first year to around 18% by year 8. This is why people who received Zostavax years ago may have been told they could receive Shingrix later.

Shingrix is substantially more effective and longer-lasting. The CDC now recommends Shingrix for all adults 50 and older, regardless of whether they previously received Zostavax. If you had Zostavax, you should receive Shingrix at least 12 months later. The two vaccines work differently enough that getting both provides better overall protection than either alone.

What happens if protection weakens over time

Even if immunity from Shingrix gradually declines after many years, the vaccine still provides meaningful protection. People who are vaccinated but later develop shingles tend to have milder disease: fewer skin lesions, shorter duration of rash, and significantly less postherpetic neuralgia. This matters because the complications of shingles—especially chronic nerve pain—cause more suffering than the infection itself.

The CDC currently does not recommend routine booster doses for most people. However, this guidance could change as more long-term data becomes available. If you are immunocompromised or have a condition that weakens your immune system, your doctor may discuss whether a booster is appropriate for you individually.

Who should get vaccinated and when

The CDC recommends Shingrix for all adults 50 and older. You do not need to have had shingles before to benefit from the vaccine—it prevents the first occurrence. If you have already had shingles, vaccination still protects you from getting it again, since the virus remains dormant in your nerve tissue.

Adults 19 and older with weakened immune systems due to disease or medication should also receive Shingrix. This includes people with HIV, those taking immunosuppressive drugs after organ transplant, and people undergoing cancer treatment. Your doctor can advise whether you fall into this category.

There is no upper age limit for vaccination. Even people in their 80s and 90s benefit from Shingrix, though the vaccine is somewhat less effective in very elderly people than in younger adults. Protection is still substantially better than no vaccination.

Side effects and what to expect after vaccination

Common side effects from Shingrix include arm soreness, muscle aches, fatigue, and headache. These typically appear within one to two days of vaccination and resolve within two to three days. The second dose is more likely to cause side effects than the first, but serious side effects are rare.

Severe allergic reactions to Shingrix are extremely uncommon. Tell your doctor before vaccination if you have had a severe reaction to any component of the vaccine, though this is unusual. Most people tolerate the vaccine well, and the temporary discomfort is far outweighed by protection against shingles.

Frequently Asked Questions

Do I need a booster shot after Shingrix?

Not currently. The CDC does not recommend routine boosters for most people vaccinated with Shingrix. Protection has been documented for at least 7 years and appears to remain strong. Guidance may change as researchers continue tracking vaccinated people over longer periods.

If I already had shingles, should I still get vaccinated?

Yes. Having shingles once does not prevent it from happening again. The virus remains in your nerve tissue for life, and vaccination reduces the risk of recurrence and the severity of disease if it does occur. Wait until the shingles rash has healed before getting vaccinated.

How long after Shingrix am I protected?

Protection begins after you receive the second dose. The first dose alone provides only partial protection. Most protection develops within two weeks of the second dose, though your immune system continues to strengthen over the following weeks.

Can I get Shingrix if I'm not sure whether I had chickenpox?

Yes. Most adults in the United States had chickenpox, even if they do not remember it clearly. Shingrix is safe and beneficial whether or not you recall having chickenpox. A blood test can confirm immunity if you are uncertain, but it is not required before vaccination.

What if I'm immunocompromised—does Shingrix still work?

Shingrix is safe for immunocompromised people and is actually recommended for them. However, the vaccine may be less effective in people with severely weakened immune systems than in healthy people. Your doctor can discuss what protection you can expect based on your specific condition.